Nov 01, 2023 / NTS GMT
Presentation
Nov 01, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Atsushi Kitamura
Astellas Pharma Inc. - CFO
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Naoki Okamura
Astellas Pharma Inc. - President, CEO & Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
UBS Investment Bank, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Miki Sogi
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst
* Seiji Wakao
JPMorgan
Q2 2024 Astellas Pharma Inc Earnings Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot